Tooth, Impacted
Conditions
Brief summary
Thirty-eight patients were randomly divided into 2 groups; the intraosseous injection group of dexamethasone (4 mg) and the submucosal injection group. All surgeries were performed by one surgeon. Postoperative pain was evaluated by visual analog scale score immediately after surgery and on postoperative days 1, 3, and 7. Swelling (determined using two linear measurements) were assessed just before the surgery and on postoperative days 1, 3, and 7 by using a digital vernier caliper. Early healing of periodontal soft tissue wound was assessed by using Early Wound Healing Score (EHS) which composed of 3 parameters: clinical signs of re-epithelization (CSR), clinical signs of hemostasis (CSH), and clinical signs of inflammation (CSI) and were assessed on postoperative days 1, 7, and 14. Mouth opening (determined by measurement of the maximum inter-incisal distance) were assessed just before the surgery and on postoperative days 1, 3, and 7 by using a digital vernier caliper.
Interventions
OTHERIntraosseus
IO dexamethasone injection Dexamethasone 4 mg
OTHERSubmucoal
SM dexamethasone injection Dexamethasone 4 mg
Sponsors
Hams Hamed Abdelrahman
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
* Patient complaining of impacted mandibular third molar mesioangular or horizontal, according to the Pell and Gregory classification 1933) * Healthy patient (American society of anesthesiologists class I status) * Patient age range from 18 to 40 years old. * Patient without any local inflammation or pathology. * Patient who will able to understand verbal and written instructions.
Exclusion criteria
* Pregnant or breast-feeding women. * Patient had anti-inflammatory drugs within 2 weeks before the procedure. * Patient under radiotherapy or chemotherapy. * Habits (heavy smoking and alcoholic). * Allergy to drugs used in this study. * Patient under anticoagulant or corticosteroid therapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in mouth opening | baseline, 1st, 3rd, 7th days | determined by measurement of the maximum inter-incisal distance assessed by using a digital vernier caliper |
| change in swelling | 1st, 3rd, 14th days | assessed by measuring two linear references (horizontal and vertical) with digital vernier caliper 1. Horizontal reference between the corner of the mouth and the tragus of the ear. 2. Vertical reference between the lateral canthus and the angle of the mandible. |
| change in pain scores | 1st, 3rd, 7th days | Pain will be assessed by using a visual analog scale (VAS) (13) immediately after surgery and on postoperative days 1, 3, and 7. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| change in early healing of periodontal soft tissue wound | 1st, 7th, 14th days | The EHS is composed of 3 parameters: 1. Clinical signs of re-epithelization (CSR). 2. Clinical signs of haemostasis (CSH). 3. Clinical signs of inflammation (CSI). |
Countries
Egypt
Outcome results
None listed